Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis



Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S
et al (show 2 more authors) (2020) Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis. ADVANCES IN THERAPY, 37 (9). 4033 - 4042.

[img] Text
Real-World Clinical Practice Use of 8-Week GlecaprevirPibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis.pdf - Published Version

Download (450kB) | Preview
Item Type: Article
Uncontrolled Keywords: Fibrosis, Hepatitis C, Infectious disease, Review, Therapeutics
Depositing User: Symplectic Admin
Date Deposited: 12 Jan 2021 10:45
Last Modified: 08 Jan 2022 18:13
DOI: 10.1007/s12325-020-01449-0
Open Access URL: http://doi.org/10.1007/s12325-020-01449-0
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3111916